A free, searchable pathogenicity resource for germline (rare disease) and somatic (cancer) variants SNVs, indels and SVs, each with a transparent ACMG/AMP evidence trail. Try one on the right.
ACMG-aligned classification against ClinVar and GenomeArc's proprietary clinical databases, spanning hereditary cancers.
AMP-guideline oncogenicity assessment pinpointing Tier 1A variants linked to FDA-approved drugs, with variant-level pharmacogenomics.
Gene, HGVS, genomic coordinate or rsID SNVs, indels and long-read SVs.
Evaluated against ACMG or AMP criteria and cross-checked with curated databases.
A traceable call with every contributing evidence code, ready for reporting.